• Je něco špatně v tomto záznamu ?

Subretinal Implantation of Human Primary RPE Cells Cultured on Nanofibrous Membranes in Minipigs

L. Lytvynchuk, A. Ebbert, H. Studenovska, R. Nagymihály, N. Josifovska, D. Rais, Š. Popelka, L. Tichotová, Y. Nemesh, J. Čížková, J. Juhásová, Š. Juhás, P. Jendelová, J. Franeková, I. Kozak, S. Erceg, Z. Straňák, B. Müller, Z. Ellederová, J....

. 2022 ; 10 (3) : . [pub] 20220314

Jazyk angličtina Země Švýcarsko

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc22009788

PURPOSE: The development of primary human retinal pigmented epithelium (hRPE) for clinical transplantation purposes on biodegradable scaffolds is indispensable. We hereby report the results of the subretinal implantation of hRPE cells on nanofibrous membranes in minipigs. METHODS: The hRPEs were collected from human cadaver donor eyes and cultivated on ultrathin nanofibrous carriers prepared via the electrospinning of poly(L-lactide-co-DL-lactide) (PDLLA). "Libechov" minipigs (12-36 months old) were used in the study, supported by preoperative tacrolimus immunosuppressive therapy. The subretinal implantation of the hRPE-nanofibrous carrier was conducted using general anesthesia via a custom-made injector during standard three-port 23-gauge vitrectomy, followed by silicone oil endotamponade. The observational period lasted 1, 2, 6 and 8 weeks, and included in vivo optical coherence tomography (OCT) of the retina, as well as post mortem immunohistochemistry using the following antibodies: HNAA and STEM121 (human cell markers); Bestrophin and CRALBP (hRPE cell markers); peanut agglutining (PNA) (cone photoreceptor marker); PKCα (rod bipolar marker); Vimentin, GFAP (macroglial markers); and Iba1 (microglial marker). RESULTS: The hRPEs assumed cobblestone morphology, persistent pigmentation and measurable trans-epithelial electrical resistance on the nanofibrous PDLLA carrier. The surgical delivery of the implants in the subretinal space of the immunosuppressed minipigs was successfully achieved and monitored by fundus imaging and OCT. The implanted hRPEs were positive for HNAA and STEM121 and were located between the minipig's neuroretina and RPE layers at week 2 post-implantation, which was gradually attenuated until week 8. The neuroretina over the implants showed rosette or hypertrophic reaction at week 6. The implanted cells expressed the typical RPE marker bestrophin throughout the whole observation period, and a gradual diminishing of the CRALBP expression in the area of implantation at week 8 post-implantation was observed. The transplanted hRPEs appeared not to form a confluent layer and were less capable of keeping the inner and outer retinal segments intact. The cone photoreceptors adjacent to the implant scaffold were unchanged initially, but underwent a gradual change in structure after hRPE implantation; the retina above and below the implant appeared relatively healthy. The glial reaction of the transplanted and host retina showed Vimentin and GFAP positivity from week 1 onward. Microglial activation appeared in the retinal area of the transplant early after the surgery, which seemed to move into the transplant area over time. CONCLUSIONS: The differentiated hRPEs can serve as an alternative cell source for RPE replacement in animal studies. These cells can be cultivated on nanofibrous PDLLA and implanted subretinally into minipigs using standard 23-gauge vitrectomy and implantation injector. The hRPE-laden scaffolds demonstrated relatively good incorporation into the host retina over an eight-week observation period, with some indication of a gliotic scar formation, and a likely neuroinflammatory response in the transplanted area despite the use of immunosuppression.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22009788
003      
CZ-PrNML
005      
20220425131551.0
007      
ta
008      
220420s2022 sz f 000 0|eng||
009      
AR
024    7_
$a 10.3390/biomedicines10030669 $2 doi
035    __
$a (PubMed)35327471
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sz
100    1_
$a Lytvynchuk, Lyubomyr $u Department of Ophthalmology, Justus Liebig University Giessen, University Hospital Giessen and Marburg GmbH, 35392 Giessen, Germany $u Karl Landsteiner Institute for Retinal Research and Imaging, 1030 Vienna, Austria
245    10
$a Subretinal Implantation of Human Primary RPE Cells Cultured on Nanofibrous Membranes in Minipigs / $c L. Lytvynchuk, A. Ebbert, H. Studenovska, R. Nagymihály, N. Josifovska, D. Rais, Š. Popelka, L. Tichotová, Y. Nemesh, J. Čížková, J. Juhásová, Š. Juhás, P. Jendelová, J. Franeková, I. Kozak, S. Erceg, Z. Straňák, B. Müller, Z. Ellederová, J. Motlík, K. Stieger, T. Ardan, G. Petrovski
520    9_
$a PURPOSE: The development of primary human retinal pigmented epithelium (hRPE) for clinical transplantation purposes on biodegradable scaffolds is indispensable. We hereby report the results of the subretinal implantation of hRPE cells on nanofibrous membranes in minipigs. METHODS: The hRPEs were collected from human cadaver donor eyes and cultivated on ultrathin nanofibrous carriers prepared via the electrospinning of poly(L-lactide-co-DL-lactide) (PDLLA). "Libechov" minipigs (12-36 months old) were used in the study, supported by preoperative tacrolimus immunosuppressive therapy. The subretinal implantation of the hRPE-nanofibrous carrier was conducted using general anesthesia via a custom-made injector during standard three-port 23-gauge vitrectomy, followed by silicone oil endotamponade. The observational period lasted 1, 2, 6 and 8 weeks, and included in vivo optical coherence tomography (OCT) of the retina, as well as post mortem immunohistochemistry using the following antibodies: HNAA and STEM121 (human cell markers); Bestrophin and CRALBP (hRPE cell markers); peanut agglutining (PNA) (cone photoreceptor marker); PKCα (rod bipolar marker); Vimentin, GFAP (macroglial markers); and Iba1 (microglial marker). RESULTS: The hRPEs assumed cobblestone morphology, persistent pigmentation and measurable trans-epithelial electrical resistance on the nanofibrous PDLLA carrier. The surgical delivery of the implants in the subretinal space of the immunosuppressed minipigs was successfully achieved and monitored by fundus imaging and OCT. The implanted hRPEs were positive for HNAA and STEM121 and were located between the minipig's neuroretina and RPE layers at week 2 post-implantation, which was gradually attenuated until week 8. The neuroretina over the implants showed rosette or hypertrophic reaction at week 6. The implanted cells expressed the typical RPE marker bestrophin throughout the whole observation period, and a gradual diminishing of the CRALBP expression in the area of implantation at week 8 post-implantation was observed. The transplanted hRPEs appeared not to form a confluent layer and were less capable of keeping the inner and outer retinal segments intact. The cone photoreceptors adjacent to the implant scaffold were unchanged initially, but underwent a gradual change in structure after hRPE implantation; the retina above and below the implant appeared relatively healthy. The glial reaction of the transplanted and host retina showed Vimentin and GFAP positivity from week 1 onward. Microglial activation appeared in the retinal area of the transplant early after the surgery, which seemed to move into the transplant area over time. CONCLUSIONS: The differentiated hRPEs can serve as an alternative cell source for RPE replacement in animal studies. These cells can be cultivated on nanofibrous PDLLA and implanted subretinally into minipigs using standard 23-gauge vitrectomy and implantation injector. The hRPE-laden scaffolds demonstrated relatively good incorporation into the host retina over an eight-week observation period, with some indication of a gliotic scar formation, and a likely neuroinflammatory response in the transplanted area despite the use of immunosuppression.
655    _2
$a časopisecké články $7 D016428
700    1_
$a Ebbert, Annabelle $u Department of Ophthalmology, Justus Liebig University Giessen, University Hospital Giessen and Marburg GmbH, 35392 Giessen, Germany $1 https://orcid.org/0000000337058989
700    1_
$a Studenovska, Hana $u Institute of Macromolecular Chemistry, Academy of Sciences of the Czech Republic, 16206 Prague, Czech Republic $1 https://orcid.org/0000000179171790
700    1_
$a Nagymihály, Richárd $u Center for Eye Research, Department of Ophthalmology, Oslo University Hospital and Institute for Clinical Medicine, Faculty of Medicine, University of Oslo, 0450 Oslo, Norway
700    1_
$a Josifovska, Natasha $u Center for Eye Research, Department of Ophthalmology, Oslo University Hospital and Institute for Clinical Medicine, Faculty of Medicine, University of Oslo, 0450 Oslo, Norway
700    1_
$a Rais, David $u Institute of Macromolecular Chemistry, Academy of Sciences of the Czech Republic, 16206 Prague, Czech Republic
700    1_
$a Popelka, Štěpán $u Institute of Macromolecular Chemistry, Academy of Sciences of the Czech Republic, 16206 Prague, Czech Republic
700    1_
$a Tichotová, Lucie $u Institute of Animal Physiology and Genetics, Academy of Sciences of the Czech Republic, 27721 Libechov, Czech Republic $u Department of Cell Biology, Faculty of Science, Charles University, 11000 Prague, Czech Republic
700    1_
$a Nemesh, Yaroslav $u Institute of Animal Physiology and Genetics, Academy of Sciences of the Czech Republic, 27721 Libechov, Czech Republic $u Department of Cell Biology, Faculty of Science, Charles University, 11000 Prague, Czech Republic $1 https://orcid.org/0000000338629413
700    1_
$a Čížková, Jana $u Institute of Animal Physiology and Genetics, Academy of Sciences of the Czech Republic, 27721 Libechov, Czech Republic
700    1_
$a Juhásová, Jana $u Institute of Animal Physiology and Genetics, Academy of Sciences of the Czech Republic, 27721 Libechov, Czech Republic
700    1_
$a Juhás, Štefan $u Institute of Animal Physiology and Genetics, Academy of Sciences of the Czech Republic, 27721 Libechov, Czech Republic $1 https://orcid.org/0000000228660727 $7 xx0105588
700    1_
$a Jendelová, Pavla $u Institute of Experimental Medicine, Academy of Sciences of the Czech Republic, 11720 Prague, Czech Republic $1 https://orcid.org/0000000246449212 $7 xx0068971
700    1_
$a Franeková, Janka $u Institute for Clinical and Experimental Medicine, 14021 Prague, Czech Republic $1 https://orcid.org/0000000250947724
700    1_
$a Kozak, Igor $u Moorfields Eye Hospital, Abu Dhabi 62807, United Arab Emirates
700    1_
$a Erceg, Slaven $u Institute of Experimental Medicine, Academy of Sciences of the Czech Republic, 11720 Prague, Czech Republic $u Research Center "Principe Felipe", Stem Cell Therapies in Neurodegenerative Diseases Laboratory, 46012 Valencia, Spain
700    1_
$a Straňák, Zbynek $u Department of Ophthalmology, University Hospital Kralovske Vinohrady and Third Faculty of Medicine, Charles University, 10034 Prague, Czech Republic $1 https://orcid.org/0000000231757212
700    1_
$a Müller, Brigitte $u Department of Ophthalmology, Justus Liebig University Giessen, University Hospital Giessen and Marburg GmbH, 35392 Giessen, Germany
700    1_
$a Ellederová, Zdenka $u Institute of Animal Physiology and Genetics, Academy of Sciences of the Czech Republic, 27721 Libechov, Czech Republic
700    1_
$a Motlík, Jan $u Institute of Animal Physiology and Genetics, Academy of Sciences of the Czech Republic, 27721 Libechov, Czech Republic
700    1_
$a Stieger, Knut $u Department of Ophthalmology, Justus Liebig University Giessen, University Hospital Giessen and Marburg GmbH, 35392 Giessen, Germany $1 https://orcid.org/0000000282985629
700    1_
$a Ardan, Taras $u Institute of Animal Physiology and Genetics, Academy of Sciences of the Czech Republic, 27721 Libechov, Czech Republic
700    1_
$a Petrovski, Goran $u Center for Eye Research, Department of Ophthalmology, Oslo University Hospital and Institute for Clinical Medicine, Faculty of Medicine, University of Oslo, 0450 Oslo, Norway $1 https://orcid.org/0000000329059252
773    0_
$w MED00205373 $t Biomedicines $x 2227-9059 $g Roč. 10, č. 3 (2022)
856    41
$u https://pubmed.ncbi.nlm.nih.gov/35327471 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20220420 $b ABA008
991    __
$a 20220425131549 $b ABA008
999    __
$a ind $b bmc $g 1784396 $s 1160986
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2022 $b 10 $c 3 $e 20220314 $i 2227-9059 $m Biomedicines $n Biomedicines $x MED00205373
LZP    __
$a Pubmed-20220420

Najít záznam

Citační ukazatele

Možnosti archivace